These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 37202028)

  • 41. Genomic epidemiology reveals multiple introductions and spread of SARS-CoV-2 in the Indian state of Karnataka.
    Pattabiraman C; Habib F; P K H; Rasheed R; Prasad P; Reddy V; Dinesh P; Damodar T; Hosallimath K; George AK; Kiran Reddy NV; John B; Pattanaik A; Kumar N; Mani RS; Venkataswamy MM; Shahul Hameed SK; Kumar B G P; Desai A; Vasanthapuram R
    PLoS One; 2020; 15(12):e0243412. PubMed ID: 33332472
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Global transmission network of SARS-CoV-2: from outbreak to pandemic.
    Skums P; Kirpich A; Baykal PI; Zelikovsky A; Chowell G
    medRxiv; 2020 Mar; ():. PubMed ID: 32511620
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Analysis of SARS-CoV-2 genomic surveillance data during the Delta and Omicron waves at a Saudi tertiary referral hospital.
    Obeid D; Al-Qahtani A; Almaghrabi R; Alghamdi S; Alsanea M; Alahideb B; Almutairi S; Alsuwairi F; Al-Abdulkareem M; Asiri M; Alshukairi A; Alkahtany J; Altamimi S; Mutabagani M; Althawadi S; Alanzi F; Alhamlan F
    J Infect Public Health; 2023 Feb; 16(2):171-181. PubMed ID: 36543031
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Is Omicron the last SARS-CoV-2 Variant of Concern?
    Rahimi F; Talebi Bezmin Abadi A
    Arch Med Res; 2022 Apr; 53(3):336-338. PubMed ID: 35093242
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Genomic surveillance during the first two years of the COVID-19 pandemic - country experience and lessons learned from Türkiye.
    Yalçın S; Coşgun Y; Dedeoğlu E; Kopp K; Bayrakdar F; Ünal G; Musul B; Sağtaş E; Korukluoğlu G; Raftery P; Kaygusuz S
    Front Public Health; 2024; 12():1332109. PubMed ID: 38855447
    [TBL] [Abstract][Full Text] [Related]  

  • 46. SARS-CoV-2 variants-associated outbreaks of COVID-19 in a tertiary institution, North-Central Nigeria: Implications for epidemic control.
    Adeyemi OO; Ndodo ND; Sulaiman MK; Ayansola OT; Buhari OIN; Akanbi OA; Bolarinwa OA; Chukwu C; Joel IY; Omoare AA; Wahab KW; Obiekea C; Buhari MO; Ahumibe A; Kolawole CF; Okoi C; Omotesho OB; Mba N; Adeniyi O; Babatunde O; Akintunde N; Ayinla G; Akande OW; Odunola RA; Saka MJ; Musa OI; Durotoye IA; Ihekweazu C; Adetifa IM; Fadeyi A
    PLoS One; 2023; 18(1):e0280756. PubMed ID: 36696405
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Combined Use of RT-qPCR and NGS for Identification and Surveillance of SARS-CoV-2 Variants of Concern in Residual Clinical Laboratory Samples in Miami-Dade County, Florida.
    Carattini YL; Griswold A; Williams S; Valiathan R; Zhou Y; Shukla B; Abbo LM; Parra K; Jorda M; Nimer SD; Sologon C; Gallegos HR; Weiss RE; Ferreira T; Memon A; Paige PG; Thomas E; Andrews DM
    Viruses; 2023 Feb; 15(3):. PubMed ID: 36992302
    [TBL] [Abstract][Full Text] [Related]  

  • 48. High throughput diagnostics and dynamic risk assessment of SARS-CoV-2 variants of concern.
    Gravagnuolo AM; Faqih L; Cronshaw C; Wynn J; Klapper P; Wigglesworth M
    EBioMedicine; 2021 Aug; 70():103540. PubMed ID: 34392145
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Early detection of SARS-CoV-2 variants through dynamic co-mutation network surveillance.
    Huang Q; Qiu H; Bible PW; Huang Y; Zheng F; Gu J; Sun J; Hao Y; Liu Y
    Front Public Health; 2023; 11():1015969. PubMed ID: 36755900
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevalence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibodies in the Mozambican Population: A Cross-Sectional Serologic Study in 3 Cities, July-August 2020.
    Arnaldo P; Mabunda N; Young PW; Tran T; Sitoe N; Chelene I; Nhanombe A; Ismael N; Júnior A; Cubula B; Inlamea OF; Gudo E; Jani IV
    Clin Infect Dis; 2022 Oct; 75(Suppl 2):S285-S293. PubMed ID: 35748663
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Opening up safely: public health system requirements for ongoing COVID-19 management based on evaluation of Australia's surveillance system performance.
    Lokuge K; D'Onise K; Banks E; Street T; Jantos S; Baptista M; Glass K
    BMC Med; 2022 Apr; 20(1):157. PubMed ID: 35421989
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dominance of Three Sublineages of the SARS-CoV-2 Delta Variant in Mexico.
    Taboada B; Zárate S; García-López R; Muñoz-Medina JE; Sanchez-Flores A; Herrera-Estrella A; Boukadida C; Gómez-Gil B; Selem Mojica N; Rosales-Rivera M; Salas-Lais AG; Gutiérrez-Ríos RM; Loza A; Rivera-Gutierrez X; Vazquez-Perez JA; Matías-Florentino M; Pérez-García M; Ávila-Ríos S; Hurtado JM; Herrera-Nájera CI; Núñez-Contreras JJ; Sarquiz-Martínez B; García-Arias VE; Santiago-Mauricio MG; Martínez-Miguel B; Enciso-Ibarra J; Cháidez-Quiróz C; Iša P; Wong-Chew RM; Jiménez-Corona ME; López S; Arias CF
    Viruses; 2022 May; 14(6):. PubMed ID: 35746637
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A small number of early introductions seeded widespread transmission of SARS-CoV-2 in Québec, Canada.
    Murall CL; Fournier E; Galvez JH; N'Guessan A; Reiling SJ; Quirion PO; Naderi S; Roy AM; Chen SH; Stretenowich P; Bourgey M; Bujold D; Gregoire R; Lepage P; St-Cyr J; Willet P; Dion R; Charest H; Lathrop M; Roger M; Bourque G; Ragoussis J; Shapiro BJ; Moreira S
    Genome Med; 2021 Oct; 13(1):169. PubMed ID: 34706766
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of COVID-19 Pandemic Waves in 10 Countries in Southern Africa, 2020-2021.
    Smith-Sreen J; Miller B; Kabaghe AN; Kim E; Wadonda-Kabondo N; Frawley A; Labuda S; Manuel E; Frietas H; Mwale AC; Segolodi T; Harvey P; Seitio-Kgokgwe O; Vergara AE; Gudo ES; Dziuban EJ; Shoopala N; Hines JZ; Agolory S; Kapina M; Sinyange N; Melchior M; Mirkovic K; Mahomva A; Modhi S; Salyer S; Azman AS; McLean C; Riek LP; Asiimwe F; Adler M; Mazibuko S; Okello V; Auld AF
    Emerg Infect Dis; 2022 Dec; 28(13):S93-S104. PubMed ID: 36502398
    [TBL] [Abstract][Full Text] [Related]  

  • 55. SARS-CoV-2 genomic characterization and clinical manifestation of the COVID-19 outbreak in Uruguay.
    Elizondo V; Harkins GW; Mabvakure B; Smidt S; Zappile P; Marier C; Maurano MT; Perez V; Mazza N; Beloso C; Ifran S; Fernandez M; Santini A; Perez V; Estevez V; Nin M; Manrique G; Perez L; Ross F; Boschi S; Zubillaga MN; Balleste R; Dellicour S; Heguy A; Duerr R
    Emerg Microbes Infect; 2021 Dec; 10(1):51-65. PubMed ID: 33306459
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Genomic epidemiology of the first epidemic wave of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Palestine.
    Qutob N; Salah Z; Richard D; Darwish H; Sallam H; Shtayeh I; Najjar O; Ruzayqat M; Najjar D; Balloux F; van Dorp L
    Microb Genom; 2021 Jun; 7(6):. PubMed ID: 34156923
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Transmission networks of SARS-CoV-2 in Coastal Kenya during the first two waves: A retrospective genomic study.
    Agoti CN; Ochola-Oyier LI; Dellicour S; Mohammed KS; Lambisia AW; de Laurent ZR; Morobe JM; Mburu MW; Omuoyo DO; Ongera EM; Ndwiga L; Maitha E; Kitole B; Suleiman T; Mwakinangu M; Nyambu JK; Otieno J; Salim B; Musyoki J; Murunga N; Otieno E; Kiiru JN; Kasera K; Amoth P; Mwangangi M; Aman R; Kinyanjui S; Warimwe G; Phan M; Agweyu A; Cotten M; Barasa E; Tsofa B; Nokes DJ; Bejon P; Githinji G
    Elife; 2022 Jun; 11():. PubMed ID: 35699426
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020-21.
    COVID-19 Excess Mortality Collaborators
    Lancet; 2022 Apr; 399(10334):1513-1536. PubMed ID: 35279232
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Protection against symptomatic infection with delta (B.1.617.2) and omicron (B.1.1.529) BA.1 and BA.2 SARS-CoV-2 variants after previous infection and vaccination in adolescents in England, August, 2021-March, 2022: a national, observational, test-negative, case-control study.
    Powell AA; Kirsebom F; Stowe J; Ramsay ME; Lopez-Bernal J; Andrews N; Ladhani SN
    Lancet Infect Dis; 2023 Apr; 23(4):435-444. PubMed ID: 36436536
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparative outcomes of extracorporeal membrane oxygenation for COVID-19 delivered in experienced European centres during successive SARS-CoV-2 variant outbreaks (ECMO-SURGES): an international, multicentre, retrospective cohort study.
    Schmidt M; Hajage D; Landoll M; Pequignot B; Langouet E; Amalric M; Mekontso-Dessap A; Chiscano-Camon L; Surman K; Finnerty D; Santa-Teresa P; Arcadipane A; Millán P; Roncon-Albuquerque R; Blandino-Ortiz A; Blanco-Schweizer P; Ricart P; Gimeno-Costa R; Albacete CL; Fortuna P; Schellongowski P; Dauwe D; Winiszewski H; Kimmoun A; Levy B; Hermans G; Grasselli G; Lebreton G; Guervilly C; Martucci G; Karagiannidis C; Riera J; Combes A;
    Lancet Respir Med; 2023 Feb; 11(2):163-175. PubMed ID: 36640786
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.